The COVID-19 vaccine will be available as soon as December this year
A large US pharmaceutical company announced that the third phase of the clinical trial report of the COVID-19 vaccine showed that the effective prevention rate of the vaccine was as high as 90%, which was far higher than the 50% requirement of the US Food and Drug Administration (FDA). The pharmaceutical company pointed out that there were 43,538 participants in the test, 94 of whom were confirmed to be infected with the new coronavirus. However, the number of people still infected with the virus has not been announced. The market estimates that if the test process goes smoothly, the vaccine will be available as early as 12 this year. Available at the beginning of the month.
Z. com Bullion is an affiliate of GMO Financial Holdings, Inc., a Japanese listed group. The risk of loss in leveraged foreign exchange trading & margin trading can be substantial. Visit the company website to read full risk warning. https://bullion.z.com/en/about/legal/risk/
Service relating to Over-the-counter (OTC) Gold Bullion/Silver trading is provided by MOL. OTC Gold/Silver Bullion trading carries a high degree of risk and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. OTC Gold/Silver Bullion is not regulated by the Securities and Futures Commission (""SFC"") and therefore trading OTC Gold/Silver Bullion will not be subject to rules or regulations promulgated by the SFC. Before deciding to trade OTC Gold/Silver Bullion you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain losses in excess of your deposited fund or even more in extreme circumstances and therefore, you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading OTC Gold/Silver Bullion, and seek advice from an independent financial advisor if you require.